Piperazine derivatives as 5ht1a antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/495 (2006.01)

Patent

CA 2191871

Compounds are disclosed which have general formula A, where R a and R b are each hydrogen or methyl and R c is hydrogen, halo or C1-4 alkyl optionally in the form of a pharmaceutically acceptable acid addition salt. The compounds are useful in the treatment of CNS disorders.

On décrit des dérivés de formule générale A, où R<a> et R<b> représentent chacun hydrogène ou méthyle et R<c> hydrogène, halo ou C1-4 alkyle, dérivés prenant éventuellement la forme d'un sel d'addition d'acide pharmacologiquement acceptable. Ces composés s'utilisent dans le traitement des troubles du système nerveux central.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazine derivatives as 5ht1a antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives as 5ht1a antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives as 5ht1a antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1563065

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.